Advances in Drug Delivery Systems for Boswellic Acids from Boswellia serrata: Enhancing Oral Bioavailability and Therapeutic Efficacy
International Journal of Molecular Sciences · 15.05.2026 · 27 (10) · 4420
DOI: 10.3390/ijms27104420 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.05.2026. Verfasst von Magdalena Rutkowska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, 1 Muszynskiego St., 90-151 Lodz, Poland. Hauptthemen laut MEDLINE: Boswellia, Triterpenes, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.
Abstract (Originalsprache)
Boswellic acids (BAs), the major bioactive constituents of Boswellia serrata oleo–gum resin, exhibit well-documented anti-inflammatory and antioxidant activities, which correspond to their healing effects in arthritis, inflammatory bowel disease, asthma, metabolic syndrome, liver disorders, and certain cancers. However, their therapeutic potential is hindered by their poor aqueous solubility, low intestinal absorption, extensive metabolism, and overall low oral bioavailability. This review provides a comprehensive analysis of conventional Boswellia serrata products and advanced drug delivery systems designed to enhance the biological performance of BAs. We summarize recent developments in formulation strategies, including phytosomes, micelles, self-emulsifying drug delivery systems, solid lipid particles, polymeric nanoparticles, hydrogels, cyclodextrin complexes, metal-based nanocarriers, and hybrid delivery platforms. Available in vivo and cellular studies are critically evaluated, with a focus on disease-specific outcomes. Results indicate that emerging formulation technologies significantly increase the oral absorption, systemic exposure, and biological effectiveness of BAs. However, despite promising preclinical data, challenges remain regarding the standardization of Boswellia extracts, the stability of novel formulations, their safety, and limited clinical evaluation. By comparing the advantages and limitations of conventional preparations with modern drug delivery systems, this review outlines the most effective strategies to enhance the bioavailability of BAs and highlights future research directions for their translational development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, 1 Muszynskiego St., 90-151 Lodz, Poland.
ORCID-Profile: Magdalena Rutkowska, Monika A Olszewska
Förderung
- Medical University of Lodz
Zitieren
APA
Rutkowska, M., & Olszewska, M. A. (2026). Advances in Drug Delivery Systems for Boswellic Acids from Boswellia serrata: Enhancing Oral Bioavailability and Therapeutic Efficacy. International Journal of Molecular Sciences, 27(10), 4420. https://doi.org/10.3390/ijms27104420
Vancouver
Rutkowska M, Olszewska MA. Advances in Drug Delivery Systems for Boswellic Acids from Boswellia serrata: Enhancing Oral Bioavailability and Therapeutic Efficacy. International Journal of Molecular Sciences. 2026;27(10):4420. doi:10.3390/ijms27104420
BibTeX
@article{Rutkowska2026,
author = {Rutkowska, Magdalena and Olszewska, Monika A},
title = {Advances in Drug Delivery Systems for Boswellic Acids from Boswellia serrata: Enhancing Oral Bioavailability and Therapeutic Efficacy},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4420},
doi = {10.3390/ijms27104420}
}
EUVIMED